Clin Mol Hepatol.
2024 Apr;30(2):263-265. 10.3350/cmh.2023.0557.
Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
- Affiliations
-
- 1Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
- KMID: 2554431
- DOI: http://doi.org/10.3350/cmh.2023.0557
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD
- Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
- Waiting for the changes after the adoption of steatotic liver disease
- No More NAFLD: The Term Is Now MASLD
